✓ Last verified: February 17, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Hartford HealthCare’s Institute of Living is one of the oldest and most respected psychiatric institutions in the United States, founded in 1822. Their Center for Interventional Psychiatry offers Spravato® (esketamine) treatment for treatment-resistant depression and major depressive disorder with suicidal ideation. As a major health system, the Institute brings extensive psychiatric expertise and the infrastructure of a full hospital setting to ketamine-based treatments.
| Google Reviews | ⭐ Major health system – Institute of Living |
| Location | Hartford, Connecticut |
| Address | 200 Retreat Avenue, Hartford, CT 06106 |
| Phone | (860) 545-7862 |
| Website | instituteofliving.org |
| Treatments | Spravato® (Esketamine) Nasal Spray, TMS, ECT, Interventional Psychiatry |
| Conditions Treated | Treatment-Resistant Depression, MDD with Suicidal Ideation, Anxiety, PTSD |
| Cost | Hospital-based pricing – Insurance typically covers Spravato® |
| Insurance | Most major insurance plans accepted through Hartford HealthCare |
| KAP Available | Spravato® (esketamine) – Contact for IV ketamine availability |
| Clinical Lead | Center for Interventional Psychiatry – Hartford HealthCare psychiatric team |
HealingMaps Take: The Institute of Living at Hartford HealthCare is a venerable name in American psychiatry, and their Center for Interventional Psychiatry brings that legacy to modern ketamine-based treatments. For patients who value the safety net of a major hospital system and broad insurance acceptance, this is one of the most established options in Connecticut. The focus here is on FDA-approved Spravato® rather than off-label IV ketamine, which may appeal to patients and referring physicians who prefer treatments with formal regulatory approval. Expect a clinical hospital environment rather than a boutique spa atmosphere.
Market Position: Hartford Healthcare is a Spravato-certified clinic in the Hartford metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. Hartford Healthcare’s posted price: Hospital-based pricing – Insurance typically covers Spravato®. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Connecticut, state-level prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
13.5% of ketamine inquiries specifically cite PTSD — second only to depression as a driver of patient demand in the HealingMaps corpus. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 4-question summary is matched to the protocols and conditions Hartford Healthcare treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Hartford Healthcare offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Hartford Healthcare treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Hartford Healthcare treats PTSD. Spravato can be used for trauma. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Hartford Healthcare treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
View all REMS-certified Spravato clinics in Connecticut and across the United States.
Leave a Reply